These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16792829)

  • 21. Implementing neonatal screening for haemoglobinopathies in the Netherlands.
    Bouva MJ; Mohrmann K; Brinkman HB; Kemper-Proper EA; Elvers B; Loeber JG; Verheul FE; Giordano PC
    J Med Screen; 2010; 17(2):58-65. PubMed ID: 20660432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening for hemoglobinopathies in medical practice: audit of gynecologists, pediatricians and generalists in Brussels].
    Hansen V; Gulbis B; Humblet P; Cotton F; Vertongen F
    Rev Med Brux; 2001 Apr; 22(2):67-72. PubMed ID: 11388025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.
    Boemer F; Vanbellinghen JF; Bours V; Schoos R
    J Med Screen; 2006; 13(3):132-6. PubMed ID: 17007654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neonatal screening for sickle cell anemia and other hemoglobinopathies in Martinique].
    Brunod M
    Med Trop (Mars); 1999; 59(4):412. PubMed ID: 10816758
    [No Abstract]   [Full Text] [Related]  

  • 25. Thalassaemia screening in a non-prevalent region of a prevalent country (Turkey): is it necessary?
    Acemoglu H; Beyhun NE; Vancelik S; Polat H; Guraksin A
    Public Health; 2008 Jun; 122(6):620-4. PubMed ID: 18222509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.
    Ballardini E; Tarocco A; Marsella M; Bernardoni R; Carandina G; Melandri C; Guerra G; Patella A; Zucchelli M; Ferlini A; Bigoni S; Ravani A; Garani G; Borgna-Pignatti C
    Blood Transfus; 2013 Apr; 11(2):245-9. PubMed ID: 23058858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neonatal diagnosis of hemoglobinopathies].
    Galactéros F
    Rev Prat; 1992 Oct; 42(15):1893-5. PubMed ID: 1485082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme.
    Al-Allawi NA; Al-Dousky AA
    East Mediterr Health J; 2010 Apr; 16(4):381-5. PubMed ID: 20795420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal screening for haemoglobinopathies: the results of a 10-year programme in an English Health Region.
    Almeida AM; Henthorn JS; Davies SC
    Br J Haematol; 2001 Jan; 112(1):32-5. PubMed ID: 11167779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for major haemoglobinopathies.
    Streetly A
    RCM Midwives; 2005 Feb; 8(2):62-3. PubMed ID: 15732614
    [No Abstract]   [Full Text] [Related]  

  • 31. Sickle cell disease: comprehensive screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Clin Pract Guidel Quick Ref Guide Clin; 1993 Apr; (6):1-13. PubMed ID: 8485604
    [No Abstract]   [Full Text] [Related]  

  • 32. Significant haemoglobinopathies: guidelines for screening and diagnosis.
    Ryan K; Bain BJ; Worthington D; James J; Plews D; Mason A; Roper D; Rees DC; de la Salle B; Streetly A;
    Br J Haematol; 2010 Apr; 149(1):35-49. PubMed ID: 20067565
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry-mass spectrometry.
    Daniel YA; Turner C; Haynes RM; Hunt BJ; Dalton RN
    Br J Haematol; 2005 Aug; 130(4):635-43. PubMed ID: 16098080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
    Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
    Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening for sickle cell disease in a Nigerian hospital.
    Odunvbun ME; Okolo AA; Rahimy CM
    Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of hemoglobinopathies in Brussels: a necessity?].
    Gulbis B; Cotton F; Hansen V; Ferster A; Toppet M; Cochaux P; Parma J; Vassart G; Fondu P; Vertongen F
    Rev Med Brux; 2001 Jun; 22(3):133-40. PubMed ID: 11488080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Haemoglobinopathy in the 21st century: incidence, diagnosis and heel prick screening].
    Suijker MH; Roovers EA; Fijnvandraat CJ; Dors N; Rodrigues Pereira R; Giordano PC; Verkerk PH; Peters M
    Ned Tijdschr Geneeskd; 2014; 158():A7365. PubMed ID: 25052352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neonatal screening of hemoglobinopathies in a population residing in Portugal].
    Peres MJ; Carreiro MH; Machado MC; Seixas T; Picanço I; Batalha L; Lavinha J; Martins MC
    Acta Med Port; 1996; 9(4-6):135-9. PubMed ID: 9005686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
    López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
    An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.